» Articles » PMID: 36962654

What Are the Barriers and Facilitators to Polio Vaccination and Eradication Programs? A Systematic Review

Overview
Specialty Public Health
Date 2023 Mar 24
PMID 36962654
Authors
Affiliations
Soon will be listed here.
Abstract

Global efforts to eradicate polio by the Global Polio Eradication Initiative agency partners and country-level stakeholders have led to the implementation of global polio vaccination programs. This study presents the findings of existing studies regarding the barriers and facilitators that countries face when implementing polio interventions. A comprehensive search was conducted in OVID Medline, OVID Embase, EBSCO CINAHL Plus, and Web of Science. Eligible studies underwent quality assessment. A qualitative evidence synthesis approach was conducted and aligned to the Consolidated Framework for Implementation Research (CFIR). The search identified 4147 citations, and following the removal of duplicates and screening according to our inclusion/exclusion criteria, 20 articles were eligible for inclusion in the review. Twelve countries were represented in this review, with India, Nigeria, Pakistan, Ethiopia, and Afghanistan having the most representation of available studies. We identified 36 barriers and 16 facilitators. Seven themes emerged from these barriers and facilitators: fear, community trust, infrastructure, beliefs about the intervention, influential opinions, intervention design, and geo-politics. The most frequently cited CFIR constructs for the facilitators and barriers were knowledge and beliefs about the intervention, followed by available resources. This study identified a wide range of barriers and facilitators to polio vaccination implementation across the globe, adding to the scarce body of literature on these barriers and facilitators from an implementation perspective and using a determinant framework. The diversity of factors among different groups of people or countries highlights the relevance of contexts. Implementers should be conversant with the contexts within which polio eradication programs boost intervention coverage and capacity. This study provides policymakers, practitioners, and researchers with a tool for planning and designing polio immunization programs. Trial registration: A protocol for this systematic review was developed and uploaded onto the PROSPERO international prospective register of systematic reviews database (Registration number: CRD42020222115).

Citing Articles

How prepared is Nigeria digital payment for health workers? A landscape analysis.

Adeniji F, Adewole D, Bello S, Ekirapa E, Aweko J, Kiberu V BMC Health Serv Res. 2025; 25(1):200.

PMID: 39901200 PMC: 11792303. DOI: 10.1186/s12913-025-12338-z.


Prevalence and associated factors of parental refusal rates for routine immunisation: a cross-sectional study in Peshawar, Khyber Pakhtunkhwa, Pakistan-2024.

Hakim M, Ali F, Zala , Pervaiz A, Afaq S, Haq Z BMC Public Health. 2025; 25(1):369.

PMID: 39881273 PMC: 11781007. DOI: 10.1186/s12889-025-21388-1.


Jonas Salk (1914-1995): Pioneering the Fight Against Polio and Beyond.

Sahu H, Choudhari S, Gaidhane A, Chakole S Cureus. 2024; 16(9):e69681.

PMID: 39429327 PMC: 11489307. DOI: 10.7759/cureus.69681.


Polio eradication: A perspective from the UK.

Simons H, Patel D New Microbes New Infect. 2024; 62:101490.

PMID: 39403552 PMC: 11472624. DOI: 10.1016/j.nmni.2024.101490.


Perceived barriers of migrants and refugees to vaccinate their children against Measles and polio: a study in Iran.

Nasiri A, Farshidi H, Rezaei F, Dehdari T, Kazemi A, Rezapour H Int J Equity Health. 2023; 22(1):253.

PMID: 38057773 PMC: 10701918. DOI: 10.1186/s12939-023-02075-2.


References
1.
Varghese J, Raman Kutty V, Ramanathan M . The interactions of ethical notions and moral values of immediate stakeholders of immunisation services in two Indian states: a qualitative study. BMJ Open. 2013; 3(3). PMC: 3612786. DOI: 10.1136/bmjopen-2012-001905. View

2.
Nilsen P . Making sense of implementation theories, models and frameworks. Implement Sci. 2015; 10:53. PMC: 4406164. DOI: 10.1186/s13012-015-0242-0. View

3.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

4.
Osaghae I, Agrawal P, Olateju A, Alonge O . Facilitators and barriers of infectious diseases surveillance activities: lessons from the Global Polio Eradication Initiative - a mixed-methods study. BMJ Open. 2022; 12(5):e060885. PMC: 9109099. DOI: 10.1136/bmjopen-2022-060885. View

5.
Lewis J, LeBan K, Solomon R, Bisrat F, Usman S, Arale A . The Critical Role and Evaluation of Community Mobilizers in Polio Eradication in Remote Settings in Africa and Asia. Glob Health Sci Pract. 2020; 8(3):396-412. PMC: 7541117. DOI: 10.9745/GHSP-D-20-00024. View